Go back to News
NEWS
Pedro Vilarinho Pires on the decision that may exclude Huawei from 5G | Observador
Observador includes in this article statements from Pedro Vilarinho Pires, Of Counsel of the Competition and European Law area and of the Technology, Media and Telecommunications (TMT) area of the Lisbon office, in the article “A technical or geopolitical decision? 13 questions on the deliberation that may exclude Huawei from 5G”.
Pedro Vilarinho Pires states that “Although it is not a legal issue, the delay in 5G implementation is a possibility that cannot be excluded, namely if the imposed restriction implies the search for replacement equipment and the reconfiguration of networks”.
Pedro Vilarinho Pires states that “Although it is not a legal issue, the delay in 5G implementation is a possibility that cannot be excluded, namely if the imposed restriction implies the search for replacement equipment and the reconfiguration of networks”.
Lawyer mentioned
Press contact
Sandra Cuesta
Director of Business Development, Marketing and Communications
Sandra Cuesta
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
PUBLICATION
¡NEW!
Use as pastiche of another person's work or rendition protected by copyright
This paper examines the recent judgment of the Court of Justice of 14 April 2026, Pelham (C-590/23, ECLI:EU:C:2026:290), which interprets the exception for pastiche contained in Directive 2001/29/EC of the European Parliament and of the Council of 22 May 2001 on the harmonisation of certain aspects of copyright and related rights in the information society.
PUBLICATION
30 Apr, 2026
Pharma & Healthcare No. 48
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
PUBLICATION
30 Apr, 2026
New customer service and telemarketing numbers
The State Secretariat for Telecommunications and Digital Infrastructures has published, on 14 April 2016, two decisions: one allocating public numbering resources to customer service and laying down the general terms of use thereof, and the other allocating public numbering resources to telemarketing and laying down the general terms of use thereof.
PUBLICATION
26 Feb, 2026
Pharma & Healthcare No. 47
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
PUBLICATION
18 Dec, 2025
Prepared for the 2026 Mobile World Congress?
The protocol, agreed jointly by the Courts of Barcelona and Alicante, provides for priority handling of applications for pre-trial examination and fact-finding orders, as well as applications for interim measures —with or without a hearing— in matters relating to patents and technological innovations, industrial designs, trademarks and copyright, as well as antitrust, unfair competition and unlawful advertising, when linked to products or presentation, display, promotion, offering or sale activities connected to MWC 2026.
PUBLICATION
09 Dec, 2025
Pharma & Healthcare No. 46
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
PUBLICATION
30 Sep, 2025
Court of Justice rules that lower courts may disregard decisions of higher courts that violate independence and impartiality
The Court of Justice ruling of 4 September 2025 (C-225/22) has declared that national courts may set aside decisions of higher courts that do not comply with the requirements of independence and impartiality derived from Article 19(1) of the Treaty on European Union and Article 47 of the Charter of Fundamental Rights of the European Union.
PUBLICATION
25 Sep, 2025
Prohibition of arbitration in the single energy market
The Agreement on the interpretation and application of the Energy Charter Treaty gives the force and effect of law to the case law of the Court of Justice of the European Union, according to which Article 26 of the Energy Charter Treaty does not and could not apply as a legal basis for intra-EU arbitration proceedings as a mechanism for the settlement of disputes between a contracting State and an investor of another contracting State.
PUBLICATION
25 Sep, 2025
Pharma & Healthcare No. 45
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.